PT  - JOURNAL ARTICLE
AU  - Sara A. Beedie
AU  - David M. St. Clair
AU  - Philip J. Benson
TI  - Atypical scanpaths in schizophrenia: Evidence of a trait- or state-dependent phenomenon?
AID  - 10.1503/jpn.090169
DP  - 2011 May 01
TA  - Journal of Psychiatry and Neuroscience
PG  - 150--164
VI  - 36
IP  - 3
4099  - http://jpn.ca/content/36/3/150.short
4100  - http://jpn.ca/content/36/3/150.full
SO  - J Psychiatry Neurosci2011 May 01; 36
AB  - The development of trait markers of schizophrenia would represent an important advance in understanding the genetic architecture of the disease. To date, no candidate markers have satisfied all of the trait marker criteria, and many are not specific to the schizophrenia spectrum. Abnormalities in visual scanpaths are frequently reported in patients with schizophrenia and are emerging as a novel candidate for a schizophrenia biomarker. Here we review the suitability of scanpath measures as a target for trait marker research in schizophrenia. Papers reporting scanpath patterns in patients with schizophrenia were identified by PubMed and Google Scholar searches and by scanning reference lists in relevant articles. Search terms included “schizophrenia,” “psychosis,” “scanpath,” “scan path,” “fixation,” “saccade” and “eye movement.” Scanpath abnormalities afford impressive sensitivity and specificity and appear largely independent of psychotropic medications. Scanpaths may demonstrate some fluctuation with symptomatology and may be useful in illuminating illness state or subtypes. However, there is evidence that viewing behaviours remain atypical regardless of symptom remission and may be present in unaffected relatives of individuals with schizophrenia. This research is in its early stages, and further investigation regarding patterns of inheritance is required. Our findings support scanpath measures as a favourable topic for further investigation as a trait marker.